- Home
- DD vs DXCM Comparison
DD vs DXCM Comparison
Compare DD & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DD
- DXCM
- Stock Information
- Founded
- DD 2015
- DXCM 1999
- Country
- DD United States
- DXCM United States
- Employees
- DD N/A
- DXCM N/A
- Industry
- DD Major Chemicals
- DXCM Medical/Dental Instruments
- Sector
- DD Industrials
- DXCM Health Care
- Exchange
- DD Nasdaq
- DXCM Nasdaq
- Market Cap
- DD 34.2B
- DXCM 32.7B
- IPO Year
- DD N/A
- DXCM 2005
- Fundamental
- Price
- DD $66.27
- DXCM $85.34
- Analyst Decision
- DD Buy
- DXCM Strong Buy
- Analyst Count
- DD 14
- DXCM 18
- Target Price
- DD $84.36
- DXCM $98.11
- AVG Volume (30 Days)
- DD 3.3M
- DXCM 4.7M
- Earning Date
- DD 05-02-2025
- DXCM 05-01-2025
- Dividend Yield
- DD 2.48%
- DXCM N/A
- EPS Growth
- DD N/A
- DXCM N/A
- EPS
- DD N/A
- DXCM 1.33
- Revenue
- DD $12,521,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- DD $6.04
- DXCM $16.49
- Revenue Next Year
- DD $4.54
- DXCM $15.45
- P/E Ratio
- DD N/A
- DXCM $64.06
- Revenue Growth
- DD 4.51
- DXCM 9.11
- 52 Week Low
- DD $53.77
- DXCM $57.52
- 52 Week High
- DD $90.06
- DXCM $132.26
- Technical
- Relative Strength Index (RSI)
- DD 50.89
- DXCM 72.77
- Support Level
- DD $64.09
- DXCM $78.55
- Resistance Level
- DD $68.37
- DXCM $72.60
- Average True Range (ATR)
- DD 1.80
- DXCM 2.79
- MACD
- DD 0.75
- DXCM 2.03
- Stochastic Oscillator
- DD 78.72
- DXCM 98.06
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.